Press Releases

Page Category:

Sonosite Reports Record Third Quarter 2004 Results

Worldwide Quarterly Revenue Increases 44% Over Prior YearCompany Reports $0.09 EPSConference Call Today at 1:30 pm PT/4:30 ETBOTHELL, WA - October 28, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today reported financial results for the quarter ended September 30, 2004. Worldwide revenue in the third quarter of 2004 grew 44% to $29.1 million compared with $20.2 million in the third quarter of 2003. For the first nine months of 2004, the Company's total revenue grew 37% to $78.7 million compared with $57.5 million for the same period of the prior year. Year-over-year, changes in foreign currency rates increased the revenue growth rate by two percentage points for the third quarter and three percentage points for the first nine months of this year. Sonosite reported net income of $1.4 million, or $0.09 per diluted share, for the third quarter of 2004, compared with a net loss of $161,000, or $0.01 per share, in the third quarter of 2003. Year-to-date, Sonosite reported a net loss of $49,000, or breakeven on a per share basis, compared with a net loss of $4.0 million, or $0.28 per share, for the first nine months of 2003.

Sonosite to Present at The RBC Dain Rauscher Client Conference

BOTHELL, WA - October 27, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the RBC Dain Rauscher Client Conference at the Seattle Sheraton on Thursday, November 4, 2004 at 08:35 am (PST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://ir.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About SonositeSonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.

Sonosite Schedules Third Quarter 2003 Financial Release and Announces Conference Call

Conference Call Accessible Via Live WebcastBOTHELL, WA - October 18, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that the Company will report its third quarter financial results on Thursday, October 28, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its third quarter performance, outlook for the rest of 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com. A replay of the audio webcast will be available beginning October 28, 2004, 4:30 pm (PDT) until November 12, 2004, 12:00 midnight (PDT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code of 981261 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com. About Sonosite

NASA/CSA to Test Sonosite TITAN Ultrasound System in Extreme Environment

US and Canada's Space Agencies Testing Medical Technology in Undersea Mission Harsh Conditions Simulate SpaceBOTHELL, WA and TORONTO - October 14, 2004 - Sonosite, (Nasdaq:SONO) the world's leader in hand-carried ultrasound, said today that TITAN, the company's compact, high performance system, will take part in a 10-day underwater experiment with NASA Extreme Environment Mission Operations (NEEMO) 7 Mission. Aquanauts will use the laptop-sized ultrasound system to scan each other in simulated emergency situations and transmit live images to St. Joseph's Healthcare in Hamilton, Ontario for review by radiologists. The NEEMO 7 mission to be conducted October 11-21, 2004 is a joint project involving the National Aeronautics and Space Administration (NASA), the Canadian Space Agency (CSA) and the Centre for Minimal Access Surgery (CMAS) at McMaster University of Hamilton, Ontario. The mission aims to demonstrate and evaluate a variety of medical diagnostic and therapeutic technologies to enhance the delivery of state-of-the-art medical care in remote and harsh environments. The experiments will take place off the coast of Key Largo, Fla, 19 meters below the surface of the sea in an underwater habitat called Aquarius. The extreme hostile environment is analogous to human space flight and has been used by NASA in the training of space station astronauts since 2001.

Sonosite Issues Statement of Support for Medical Societies’ Policies Regarding Entertainment Use of Ultrasound

SEATTLE, WA - September 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in hand-carried ultrasound technology, joined today with leading medical societies in speaking out against the non-medical practice of "keepsake ultrasounds." "The AIUM and other medical societies have been very concerned that so called "entertainment or keepsake sonograms" performed outside a diagnostic facility with no medical supervision represent an inappropriate use of ultrasound technology and are contrary to responsible medical practice," said Lewis H. Nelson, III, MD, RDMS, president of the American Institute of Ultrasound in Medicine (AIUM). "We commend Sonosite for its support in discouraging the improper use of ultrasound technology." The AIUM is a leading accrediting body for medical ultrasound facilities and laboratories. The multidisciplinary organization represents over 9,000 medical professionals utilizing diagnostic ultrasound including radiologists, cardiologists, interventionalists, surgeons, vascular specialists, OB/Gyns, sonographers and scientists. Other medical societies expressing concern about the commercial, non-medical use of ultrasound are the American College of Obstetricians and Gynecologists (ACOG), the American College of Radiology (ACR) and the Society of Diagnostic Medical Sonography (SDMS).

Sonosite to Present at the 2004 UBS Global Life Sciences Conference

BOTHELL, WA - September 17, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 29, 2004 at 10:30 a.m. (EDT). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About SonositeSonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.

ACG Presents Regional Emerging Growth Awards to Sonosite and Quinton Cardiology Systems

SEATTLE, September 10, 2004 - The Association for Corporate Growth, Seattle Chapter, announced today that it has awarded the ACG Seattle Regional Emerging Growth Award to Quinton Cardiology Systems, Inc. and Sonosite, Inc. The awards were presented at an ACG Seattle event at the Washington Athletic Club on September 8, 2004. Quinton CEO John Hinson and Sonosite CEO Kevin Goodwin spoke at the event, which was taped and televised on TVW - Washington State's Public Affairs Network.Every year the Association for Corporate Growth (ACG Global) presents the Outstanding Growth Award and the Emerging Company Award to two companies, honoring them for sustained excellence in corporate growth and financial performance. This year, for the very first time, ACG Seattle established a regional award and nominated two firms for the ACG Global Emerging Company Award.This award recognized companies for superior growth for at least the last three years, and is awarded to qualifying companies with revenues under $500 million in the most recent fiscal year.

Sonosite and Mediwatch Sign Distribution and Development Agreements for Urology Market

Mediwatch to Distribute Sonosite Products to UK Urology MarketSonosite Technology to be Incorporated into Mediwatch's Prostate Assessment ProductLONDON, September 2, 2004 - Sonosite Inc. (Nasdaq: SONO), the worldwide leader in high performance, hand-carried ultrasound, announced today that Sonosite, Ltd., the Company's United Kingdom (UK) subsidiary, has entered into two distribution and supply agreements with Mediwatch Plc., (LSE:MDW.L) a leading developer, manufacturer and distributor of advanced urological primary care products for the screening, diagnosis and assessment of urological disease and disorders. Under the terms of the first agreement, Mediwatch will become an authorised distributor of Sonosite's hand-carried ultrasound systems for the UK urology market. Pursuant to the second agreement, Sonosite will supply Mediwatch with its TITAN ultrasound technology to be incorporated into Mediwatch's proprietary 'One Stop' Prostate Assessment System, which is currently under development and Mediwatch intends to market worldwide when completed. Mediwatch's 'One Stop' Prostate Assessment System is designed to provide the physician with a complete system for the diagnosis and assessment of prostate health in the clinic and will include imaging, urinalysis and blood testing capabilities.

Sonosite Announces Boston Scientific To Distribute Its iLook Hand-Carried Ultrasound In U.S. vascular access and interventional markets

SEATTLE - August 11, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in high-performance, hand-carried ultrasound technology, today announced that it has entered into a multi-year agreement with Boston Scientific Corporation (NYSE: BSX) under which Boston Scientific's Oncology Division will serve as the exclusive distributor of Sonosite's iLook ultrasound systems for select U.S. vascular access and interventional markets. The agreement covers U.S. distribution of Sonosite's iLook 15 and iLook 25 hand-carried ultrasound systems for the guidance of medical procedures such as placement of intravenous catheters, ports and other long-dwelling implants for interventional radiology, nephrology, oncology and general/vascular surgery applications. It is expected that Boston Scientific will begin distribution later in the third quarter upon completion of transfer of sub-distribution rights pursuant to Sonosite's contracts with hospital purchasing organizations. The agreement extends through 2008 with the option for renewal. Weighing only 3 pounds, the all-digital iLook system is specifically designed...

Sonosite Reports New Option Grant Under Nasdaq Market Rule 4350

BOTHELL, WA, August 2, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced that, in accordance with Nasdaq Marketplace Rule 4350, a non-officer employee was granted inducement stock options for 15,000 shares of common stock on July 27, 2004. These options were granted pursuant to Nasdaq Marketplace Rule 4350 (i)(1)(A)(iv). Each option has been classified as a non-qualified stock option, has an exercise price equal to the fair market value on the grant date, has a ten-year term, and vests 25% on the one year anniversary of the option grant date with an additional 2.0833% vested each month thereafter, with 100% being vested and exercisable four years from the option grant date.About SonositeSonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.

+1 425 951 1200